ABOUT

MYELOID

At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies and unleash the power of myeloid cells in cancer.

​

Our proprietary ATAK™ platform is designed to designed to turn myeloid cells against tumors. These engineered cells find, recognize and penetrate tumors. These cells also prime other elements of the immune system, including T cells, thereby reinforcing the anti-tumor immune response, culminating in cancer eradication.   

AdobeStock_18058273 cube_fnl_lo.png

THE

Myeloid is powered by the discoveries of our founders – a group of world-leading scientists whose expertise spans oncology, immunology, mRNA biology, cell therapy, synthetic biology, and gene delivery.

 

We’re building a team of talented, driven scientists and other biotech industry experts to turn these discoveries into novel, life-saving treatments for people navigating life with cancer.

 

TEAM

LEADERSHIP

DarrenBaccia34_Real_lo.png
DarrenBaccia34_silhouette_lo.png

Chief Business Officer

Darren Braccia

MicheleGerber15_web_Silhouette_real_lo c
MicheleGerber15_web_Silhouettelo copy.pn

MD, MPH

Chief Medical Officer

Michele Gerber

bruce_Adjusted copy.png
bruce_Rng_silhouette.png

Chief Science Officer

Bruce McCreedy, PhD

E Jones Mar 2020_12-cutout.png
E Jones Mar 2020_12 copy.png

Board Director

Elaine Jones

PhD

TCahill1_Real_lo.png
TCahill1_Silhouette_Lo.png

President; Newpath Partners

Thomas Cahill

MD PhD

Daniel Getts_web_Silhouette_reallo copy.
Daniel Getts_web_Silhouette_lo.png

MBA, PhD

Chief Executive Officer

Daniel Getts

Yuxiao_cutout.png
yuxiao_Silhoutte copy.png

Co-Founder

Yuxiao Wang
PhD

FOUNDERS

Siddhartha-2015_Team_lo.png
Siddhartha-2015_Team_lo copy.png

MD Phil

Founder & Chair - Advisory Board

Siddhartha Mukherjee
Ronald-Vale-400x400_adjust_cutout.png
Ronald_Vale_Silhouette.png

Founder

Ronald Vale, PhD

FOUNDERS
LEADERSHIP
Daniel Getts_web_Silhouette_reallo copy.

Daniel Getts

Chief Executive Officer

BruceMcCreedy27_Adj_500px_edited.png

Bruce McCreedy, PhD

Chief Science Officer

E Jones Mar 2020_12 copy.png

Elaine Jones, PhD

Board Director

DarrenBaccia34_Real_lo.png

Darren Braccia

Chief Business Officer

SadettinOzturk12_cu_lo-600px_edited.png

Sadettin Ozturk, PhD

Chief Technology & Manufacturing Officer 

TCahill1_Real_lo_edited.png

Thomas Cahill, MD, PhD

Co-Founder and President

MicheleGerber15_web_Silhouette_real_lo copy_edited.png

Michele Gerber, MD, MPH

Chief Medical Officer

MicheleCioffi41_adj_500px_edited_edited.png

Michele Cioffi

VP, Clinical Operations

Ronald-Vale-400x400_adjust_cutout.png

Ronald Vale, PhD

Founder

Siddhartha-2015_Team_lo.png

Siddhartha Mukherjee,
MD, DPhil

Founder & Chair of Advisory Board

Yuxiao_cutout.png

Yuxiao Wang, PhD

Co-founder & Sr. Director,

Discovery Research

FOUNDERS
Ronald-Vale-400x400_adjust_cutout.png

Ronald Vale, PhD

Founder

Siddhartha-2015_Team_lo.png

Siddhartha Mukherjee,
MD, DPhil

Founder & Chair of Advisory Board

Yuxiao_cutout.png

Yuxiao Wang, PhD

Co-founder & Sr. Director,

Discovery Research

NewpathLogo_lo.png
ARE_Proprietary_Products_RGB_VentureInve
hatteraslogos-rev_new_400 copy.png
8VC-logo-black.png
INVESTORS

SCIENTIFIC ADVISORY BOARD

Clinical Cell

Therapy Advisors

Immunology, Virology & Myeloid Cell Advisors